Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma
Biomacromolecules · 09.11.2026 · 27 (11) · 7625-7639
DOI: 10.1021/acs.biomac.6c01684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 14.10.2026. Verfasst von Giuseppina Daniela Naimo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Health and Nutritional Science, University of Calabria, Rende (CS)87036, Italy. Hauptthemen laut MEDLINE: Doxorubicin, Glioblastoma, Nanoparticles, Drug Delivery Systems. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università della Calabria, Universit? della Calabria.
Abstract (Originalsprache)
We engineered a protein-based nanoplatform exploiting the intrinsic disulfide network of human serum albumin (HSA) to generate self-crosslinked, redox-responsive nanoparticles without synthetic crosslinking agents. Following folic acid conjugation, HSA nanoparticles (f-HNPs) were prepared by desolvation-assisted self-crosslinking and loaded with doxorubicin (DOX) with 88% encapsulation efficiency. The resulting nanoparticles were spherical, with an average diameter of 37 ± 5 nm and PDI of 0.24, and underwent glutathione-triggered destabilization and accelerated drug release under reducing conditions. Empty f-HNPs showed excellent biocompatibility, whereas DOX@f-HNPs enhanced DOX cytotoxicity against U-87MG glioblastoma cells, reducing the IC50 from 0.24 to 0.17 μg mL−1. Competitive inhibition experiments supported folate receptor-mediated uptake and enhanced intracellular drug accumulation. Nanoparticle-mediated delivery increased oxidative stress, mitochondrial depolarization, and G2/M cell-cycle arrest, accompanied by p21 upregulation, Cyclin D1 and Ki67 downregulation, and sustained inhibition of glioblastoma cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Health and Nutritional Science, University of Calabria, Rende (CS)87036, Italy.
ORCID-Profile: Giuseppe Cirillo, Manuela Curcio, Antonella Leggio, Diana Amantea
Förderung
- Università della Calabria
- Universit? della Calabria
Zitieren
APA
Naimo, G. D., Cirillo, G., Curcio, M., Scorzafave, L., Fiore, M., Giordano, F., Leggio, A., Amantea, D., Nicoletta, F. P., Mauro, L., & Iemma, F. (2026). Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma. Biomacromolecules, 27(11), 7625-7639. https://doi.org/10.1021/acs.biomac.6c01684
Vancouver
Naimo GD, Cirillo G, Curcio M, Scorzafave L, Fiore M, Giordano F, et al. Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma. Biomacromolecules. 2026;27(11):7625-7639. doi:10.1021/acs.biomac.6c01684
BibTeX
@article{Naimo2026,
author = {Naimo, Giuseppina Daniela and Cirillo, Giuseppe and Curcio, Manuela and Scorzafave, Ludovica and Fiore, Marco and Giordano, Francesca and Leggio, Antonella and Amantea, Diana and Nicoletta, Fiore Pasquale and Mauro, Loredana and Iemma, Francesca},
title = {Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {11},
pages = {7625--7639},
doi = {10.1021/acs.biomac.6c01684}
}
EUVIMED